Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

PIP2 dependence of Kv7 Channel Pharmacology

EF 2024-25

Résumé
Kv7 channels are voltage-gated potassium channels expressed throughout the nervous system, and mutations that disrupt function or expression of Kv7 channels are linked to a spectrum of neurological disorders. For example, self-limited familial neonatal epilepsy is a rare form of epilepsy that typically resolves within 15 weeks of age - treatment is essential because seizures in this stage can cause severe mental complications and death. Kv7 mutations can also lead to more severe and long-lasting epileptic encephalopathy and developmental delay. Kv7-linked diseases are frequently pharmacoresistant, underlining a need for novel approaches to treat these conditions. Enhanced Kv7 channel activity suppresses neuronal excitability, therefore understanding their regulation and pharmacology may contribute to the ongoing development of Kv7-targeted anti-seizure drugs. Kv7 channel activity depends on levels of the membrane phospholipid PIP2. PIP2 is depleted during seizures, but it is not known how this affects drug actions. This project will quantitatively describe how altered PIP2 levels influence responses to Kv7 channel activator drugs, and will also identify drugs that promote Kv7 channel expression at the cell surface. Channel responses to Kv7 activator drugs will be explored using patch-clamp electrophysiology, together with tools to manipulate cellular levels of PIP2. High content confocal microscopy will be used to screen for drugs that rescue cell surface expression of Kv7 channels. The expected outcome of this project is to improve our understanding of regulatory mechanisms that are vital to Kv7 pharmacology. As a result, this can ultimately contribute towards the development of more effective therapeutic strategies to treat related conditions.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529774
Name
Hammond Thomas M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
PIP2 dependence of Kv7 Channel Pharmacology
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biophysics; Electrophysiology; Epilepsy; Ion Channel; Kv7; Neuroscience
Abstract
Kv7 channels are voltage-gated potassium channels expressed throughout the nervous system, and mutations that disrupt function or expression of Kv7 channels are linked to a spectrum of neurological disorders. For example, self-limited familial neonatal epilepsy is a rare form of epilepsy that typically resolves within 15 weeks of age - treatment is essential because seizures in this stage can cause severe mental complications and death. Kv7 mutations can also lead to more severe and long-lasting epileptic encephalopathy and developmental delay. Kv7-linked diseases are frequently pharmacoresistant, underlining a need for novel approaches to treat these conditions. Enhanced Kv7 channel activity suppresses neuronal excitability, therefore understanding their regulation and pharmacology may contribute to the ongoing development of Kv7-targeted anti-seizure drugs. Kv7 channel activity depends on levels of the membrane phospholipid PIP2. PIP2 is depleted during seizures, but it is not known how this affects drug actions. This project will quantitatively describe how altered PIP2 levels influence responses to Kv7 channel activator drugs, and will also identify drugs that promote Kv7 channel expression at the cell surface. Channel responses to Kv7 activator drugs will be explored using patch-clamp electrophysiology, together with tools to manipulate cellular levels of PIP2. High content confocal microscopy will be used to screen for drugs that rescue cell surface expression of Kv7 channels. The expected outcome of this project is to improve our understanding of regulatory mechanisms that are vital to Kv7 pharmacology. As a result, this can ultimately contribute towards the development of more effective therapeutic strategies to treat related conditions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hammond, Thomas M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~